COVID-19 Vaccine Hesitancy among Behavioral Risk Takers
Abstract
:1. Background
2. Methods
2.1. Study Population
2.2. Measures
2.3. Data Analysis
2.4. Ethical Compliance
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Gentil, J. Vaccine refusal/hesitancy—the ethical point of view. Eur. J. Public Health 2021, 31 (Suppl. 2), ckab120.029. [Google Scholar] [CrossRef]
- Vaccines and Immunization. Available online: https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1 (accessed on 20 February 2022).
- US Coronavirus Vaccine Tracker. Available online: https://usafacts.org/visualizations/covid-vaccine-tracker-states/ (accessed on 20 February 2022).
- COVID Live-Coronavirus Statistics-Worldometer. Available online: https://www.worldometers.info/coronavirus/#countries (accessed on 20 February 2022).
- Gowda, C.; Dempsey, A.F. The rise (and fall?) of parental vaccine hesitancy. Hum. Vaccin. Immunother. 2013, 9, 1755–1762. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Razai, M.S.; Chaudhry, U.A.R.; Doerholt, K.; Bauld, L.; Majeed, A. COVID-19 vaccination hesitancy. BMJ 2021, 373, n1138. [Google Scholar] [CrossRef] [PubMed]
- Randolph, H.E.; Barreiro, L.B. Herd Immunity: Understanding COVID-19. Immunity 2020, 52, 737–741. [Google Scholar] [CrossRef]
- National Institutes of Health (NIH). Decline in Measles Vaccination Is Causing a Preventable Global Resurgence of the Disease. 2019. Available online: https://www.nih.gov/news-events/news-releases/decline-measles-vaccination-causing-preventable-global-resurgence-disease (accessed on 23 February 2022).
- Paules, C.I.; Marston, H.D.; Fauci, A.S. Measles in 2019—Going Backward. N. Engl. J. Med. 2019, 380, 2185–2187. [Google Scholar] [CrossRef]
- Soares, P.; Rocha, J.V.; Moniz, M.; Gama, A.; Laires, P.A.; Pedro, A.R.; Dias, S.; Leite, A.; Nunes, C. Factors Associated with COVID-19 Vaccine Hesitancy. Vaccines 2021, 9, 300. [Google Scholar] [CrossRef]
- Wang, J.; Jing, R.; Lai, X.; Zhang, H.; Lyu, Y.; Knoll, M.D.; Fang, H. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines 2020, 8, 482. [Google Scholar] [CrossRef]
- Murphy, J.; Vallières, F.; Bentall, R.P.; Shevlin, M.; McBride, O.; Hartman, T.K.; McKay, R.; Bennett, K.; Mason, L.; Gibson-Miller, J.; et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021, 12, 29. [Google Scholar] [CrossRef]
- Fisher, K.A.; Bloomstone, S.J.; Walder, J.; Crawford, S.; Fouayzi, H.; Mazor, K.M. Attitudes Toward a Potential SARS-CoV-2 Vaccine. Ann. Intern. Med. 2020, 173, 964–973. [Google Scholar] [CrossRef]
- COVID-19 Vaccination and Case Trends by Age Group, United States|Data|Centers for Disease Control and Prevention. Available online: https://data.cdc.gov/Vaccinations/COVID-19-Vaccination-and-Case-Trends-by-Age-Group-/gxj9-t96f (accessed on 20 February 2022).
- UCLA Center for Health Policy Research. Design & Methods. Available online: https://healthpolicy.ucla.edu/chis/design/Pages/2019-2020-methods.aspx (accessed on 7 March 2022).
- Zhang, J.; Dean, J.; Yin, Y.; Wang, D.; Sun, Y.; Zhao, Z.; Wang, J. Determinants of COVID-19 Vaccine Acceptance and Hesitancy: A Health Care Student-Based Online Survey in Northwest China. Front. Public. Health 2022, 9, 777565. Available online: https://www.frontiersin.org/article/10.3389/fpubh.2021.777565 (accessed on 23 February 2022). [CrossRef]
- Mant, M.; Aslemand, A.; Prine, A.; Holland, A.J. University students’ perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study. PLoS ONE 2021, 16, e0255447. [Google Scholar] [CrossRef] [PubMed]
- Hoogink, J.; Verelst, F.; Kessels, R.; van Hoek, A.J.; Timen, A.; Willem, L.; Beutels, P.; Wallinga, J.; de Wit, G.A. Preferential differences in vaccination decision-making for oneself or one’s child in The Netherlands: A discrete choice experiment. BMC Public Health 2020, 20, 828. [Google Scholar] [CrossRef] [PubMed]
- Ert, E.; Yechiam, E.; Arshavsky, O. Smokers’ Decision Making: More than Mere Risk Taking. PLoS ONE 2013, 8, e68064. [Google Scholar] [CrossRef] [Green Version]
- Brown, A.; Collins, J.M.; Schmeiser, M.D.; Urban, C. State Mandated Financial Education and the Credit Behavior of Young Adults; Report No.: ID 2498087; Social Science Research Network: Rochester, NY, USA, 2014; Available online: https://papers.ssrn.com/abstract=2498087 (accessed on 23 February 2022).
- Goniewicz, M.L.; Delijewski, M. Nicotine vaccines to treat tobacco dependence. Hum. Vaccin. Immunother. 2013, 9, 13–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ganczak, M.; Pasek, O.; Duda-Duma, Ł.; Komorzycka, J.; Nowak, K.; Korzeń, M. A Peer-Based Educational Intervention Effects on SARS-CoV-2 Knowledge and Attitudes among Polish High-School Students. Int. J. Environ. Res. Public Health 2021, 18, 12183. [Google Scholar] [CrossRef]
- Pasek, O.; Michalska, J.; Piechowicz, M.; Stoliński, M.; Ganczak, M. Effect of peer-education on the willingness to vaccinate against COVID-19 among high school students. Eur. J. Public Health 2021, 31 (Suppl. 3), ckab164.536. [Google Scholar] [CrossRef]
- Graupensperger, S.; Abdallah, D.A.; Lee, C.M. Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine. Vaccines 2021, 39, 2060–2067. [Google Scholar] [CrossRef]
- Tuskegee Study-Timeline-CDC-NCHHSTP. 2021. Available online: https://www.cdc.gov/tuskegee/timeline.htm (accessed on 23 February 2022).
- Bajaj, S.S.; Stanford, F.C. Beyond Tuskegee—Vaccine Distrust and Everyday Racism. N. Engl. J. Med. 2021, 384, e12. [Google Scholar] [CrossRef]
- Lahijani, A.Y.; King, A.R.; Gullatte, M.M.; Hennink, M.; Bednarczyk, R.A. HPV Vaccine Promotion: The church as an agent of change. Soc. Sci. Med. 2021, 268, 113375. [Google Scholar] [CrossRef]
- Rowland, M.L.; Isaac-Savage, E.P. As I See It: A Study of African American Pastors’ Views on Health and Health Education in the Black Church. J. Relig. Health 2014, 53, 1091–1101. [Google Scholar] [CrossRef]
- Latkin, C.A.; Edwards, C.; Davey-Rothwell, M.A.; Tobin, K.E. The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addict. Behav. 2017, 73, 133–136. [Google Scholar] [CrossRef] [PubMed]
- Design & Methods | UCLA Center for Health Policy Research. Available online: https://healthpolicy.ucla.edu/chis/design/pages/methodology.aspx (accessed on 20 February 2022).
- UCLA Center for Health Policy Research. Strengths and Limitations of AskCHIS, AskCHIS NE and CHIS. Available online: http://healthpolicy.ucla.edu/chis/Documents/AskCHIS%20Training%20Tech%20Assist%20Articles%202017/Strengths%20and%20limitation%20of%20CHIS.pdf (accessed on 20 February 2022).
- California Tobacco Laws that Reduce ETS Exposure|California Air Resources Board. Available online: https://ww2.arb.ca.gov/our-work/programs/environmental-tobacco-smoke/california-tobacco-laws-reduce-ets-exposure (accessed on 18 February 2022).
- Jarrett, C.; Wilson, R.; O’Leary, M.; Eckersberger, E.; Larson, H.J. Strategies for addressing vaccine hesitancy-A systematic review. Vaccines 2015, 33, 4180–4190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Variables | N, % |
---|---|
Sex | |
Male | 1,983,978 (49.26) |
Female | 2,043,484 (50.74) |
Race/Ethnicity | |
White | 958,595 (23.80) |
African-American | 181,189 (4.50) |
Latino | 1,392,649 (34.58) |
Asian | 605,869 (15.04) |
Other | 889,160 (22.08) |
Poverty | |
200% FPL or more | 2,377,168 (59.02) |
Less than 200% FPL | 1,650,294 (40.98) |
Education | |
High School or Less | 1,606,588 (39.89) |
Some College, Vocational, Associates | 1,375,100 (34.14) |
Bachelors or higher | 1,045,774 (25.97) |
Insurance | |
Not all insured past 12 months | 721,408 (17.91) |
Insured all past 12 months | 3,306,054 (82.09) |
Weight Status (based on mass index) | |
Normal or Underweight | 2,330,505 (57.87) |
Overweight or Obese | 1,696,957 (42.13) |
Smoking Status | |
Current Smoker | 338,995 (8.42) |
Not Current Smoker | 3,688,467 (91.58) |
Past Year Psychological Distress | |
Yes | 1,186,666 (29.46) |
No | 2,840,796 (70.54) |
General Health Status | |
Excellent/Very good/good | 3,650,407 (90.64) |
Fair/Poor | 377,055 (9.36) |
Had COVID/COVID-Symptoms | |
Yes | 621,082 (15.42) |
No | 3,406,380 (84.58) |
Illicit Drug Use | |
Yes | 138,367 (3.44) |
No | 3,889,095 (96.56) |
Will take COVID Vaccine | |
Yes | 3,081,047 (76.50) |
No | 946,415 (23.50) |
Variables | % |
---|---|
Sex | |
Male | 24.34 |
Female | 22.68 |
Race/Ethnicity | *** |
White | 20.23 |
African-American | 51.48 |
Latino | 24.37 |
Asian | 10.47 |
Other | 28.83 |
Poverty | |
200% FPL or more | 22.94 |
Less than 200% FPL | 24.31 |
Education | *** |
High School or Less | 34.48 |
Some College, Vocational, Associates | 18.54 |
Bachelor’s or higher | 13.15 |
Insurance | |
Not all insured past 12 months | 28.48 |
Insured all past 12 months | 22.41 |
Weight status (based on mass index) | * |
Normal or Underweight | 20.62 |
Overweight or Obese | 27.45 |
Smoking Status | * |
Current Smoker | 35.51 |
Not Current Smoker | 22.40 |
Past Year Psychological Distress | |
Yes | 20.17 |
No | 24.89 |
General Health Status | * |
Excellent/Very good/good | 22.37 |
Fair/Poor | 34.41 |
Had COVID/COVID-Symptoms | |
Yes | 23.05 |
No | 23.58 |
Illicit Drug Use | |
Yes | 19.33 |
No | 23.65 |
Variables | OR (95% CI) |
---|---|
Sex | |
Male | Ref. |
Female | 1.11 (0.80, 1.53) |
Race/Ethnicity | |
White | Ref. |
African-American | 3.64 (1.56, 8.47) ** |
Latino | 1.08 (0.64, 1.81) |
Asian | 0.52 (0.27, 0.99) * |
Other | 1.29 (0.82, 2.05) |
Poverty | |
200% FPL or more | Ref. |
Less than 200% FPL | 0.80 (0.54, 1.18) |
Education | |
High School or Less | 3.35 (2.15, 5.22) *** |
Some College, Vocational, Associates | 1.54 (0.98, 2.43) |
Bachelor’s or higher | Ref. |
Insurance | |
Not all insured past 12 months | 1.32 (0.79, 2.19) |
Insured all past 12 months | Ref. |
Weight status (based on mass index) | |
Normal or Underweight | Ref. |
Overweight or Obese | 1.24 (0.85, 1.81) |
Smoking Status | |
Current Smoker | 2.16 (1.12, 4.15) * |
Not Current Smoker | Ref. |
Past Year Psychological Distress | |
Yes | 0.64 (0.42, 0.98) * |
No | Ref. |
General Health Status | |
Excellent/Very good/good | Ref. |
Fair/Poor | 1.62 (0.80, 3.29) |
Had COVID/COVID-Symptoms | |
Yes | 1.35 (0.80, 2.29) |
No | Ref. |
Illicit Drug Use | |
Yes | 0.76 (0.34, 1.66) |
No | Ref. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Becerra, M.B.; Becerra, B.J. COVID-19 Vaccine Hesitancy among Behavioral Risk Takers. Vaccines 2022, 10, 767. https://doi.org/10.3390/vaccines10050767
Becerra MB, Becerra BJ. COVID-19 Vaccine Hesitancy among Behavioral Risk Takers. Vaccines. 2022; 10(5):767. https://doi.org/10.3390/vaccines10050767
Chicago/Turabian StyleBecerra, Monideepa B., and Benjamin J. Becerra. 2022. "COVID-19 Vaccine Hesitancy among Behavioral Risk Takers" Vaccines 10, no. 5: 767. https://doi.org/10.3390/vaccines10050767
APA StyleBecerra, M. B., & Becerra, B. J. (2022). COVID-19 Vaccine Hesitancy among Behavioral Risk Takers. Vaccines, 10(5), 767. https://doi.org/10.3390/vaccines10050767